Chan A, Cohan S, Stark J, et al. Treatment with delayed-release dimethyl fumarate is associated with fewer relapses versus glatiramer acetate in patients with relapsing remitting multiple sclerosis: real-world comparative effectiveness analyses from the EFFECT study. ECTRIMS 2017, P1160.
Veiligheid en effectiviteit van nabiximols voor spasticiteit bij ‘motor-neuron disease’
apr 2019 | Neuro-musculair